Shattuck Labs (STTK) Non-Current Deffered Revenue (2019 - 2021)
Shattuck Labs (STTK) reported Non-Current Deffered Revenue of $2.2 million for Q4 2021, up 124.21% year-over-year from $987000.0 in Q4 2020, and down 91.89% quarter-over-quarter from $27.3 million in Q3 2021.
Shattuck Labs (STTK) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Shattuck Labs (STTK) has 3 years of Non-Current Deffered Revenue data on file, last reported at $2.2 million in Q4 2021.
- Non-Current Deffered Revenue for Q4 2021 came in at $2.2 million, up 124.21% year-over-year; the trailing twelve-month figure through Dec 2021 was $2.2 million (up 124.21% YoY), and the FY2021 annual result was $2.2 million, up 124.21% from the prior year.
- Non-Current Deffered Revenue slipped to $2.2 million in Q4 2021 per STTK's latest filing, from $27.3 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $27.3 million in Q3 2021 and troughed at $911000.0 in Q3 2020.
- A 3-year average of $6.5 million and a median of $2.2 million in 2021 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2020 and 2021: Non-Current Deffered Revenue sank 89.69% in 2020, then surged 2894.18% in 2021.
- A 3-year view of Non-Current Deffered Revenue shows it stood at $9.6 million in 2019, then slumped by 89.69% to $987000.0 in 2020, then soared by 124.21% to $2.2 million in 2021.
- Business Quant data shows STTK's Non-Current Deffered Revenue at $2.2 million in Q4 2021, $27.3 million in Q3 2021, and $2.4 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.21 Mn |
| Sep 30, 2021 | 27.28 Mn |
| Jun 30, 2021 | 2.37 Mn |
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 987,000.00 |
| Sep 30, 2020 | 911,000.00 |
| Dec 31, 2019 | 9.57 Mn |